Literature DB >> 31209684

Pediatric heterozygous familial hypercholesterolemia patients have locally increased aortic pulse wave velocity and wall thickness at the aortic root.

Andrew Tran1, Barbara Burkhardt2, Animesh Tandon3, Sarah Blumenschein3, Arna van Engelen4, Marina Cecelja5, Song Zhang6, Sergio Uribe7,8,9, Joaquin Mura9,10, Gerald Greil3,4, Tarique Hussain3,4.   

Abstract

Familial hypercholesterolemia (FH) is an autosomal dominant disorder that affects 1 in 250 people. Aortic stiffness, measured by pulse wave velocity (PWV), is an independent predictor for cardiovascular events. Young FH patients are a unique group with early vessel wall disease that may serve to elucidate the determinants of aortic stiffness. We hypothesized that young FH patients would have early changes in aortic stiffness compared to healthy, age- and sex-matched reference values. Thirty-three FH patients ( ≥ 7 years age; mean age 14.6 ± 3.3 years; 26/33 on statin therapy) underwent cardiac MRI. PWV was determined using propagation of flow waveform from aortic arch phase contrast images. Distensibility and aortic wall thickness (AWT) were measured at the ascending, proximal descending, and diaphragmatic aorta. Ventricular volumes and left ventricular (LV) myocardial mass were measured from 2D cine images. These parameters were compared to age- and sex-matched reference values. FH patients had significantly higher PWV (4.5 ± 0.8 vs. 3.5 ± 0.3 m/s; p < 0.001), aortic distensibility, and ascending aortic wall thickness (1.37 ± 0.18 vs. 1.30 ± 0.02 mm; p < 0.05) compared to reference. There was no difference in aortic area or descending aortic wall thickness between groups. Young FH patients had aortic changes with increased aortic pulse wave velocity in the setting of increased aortic distensibility, accompanied by increased thickness of the ascending aortic wall. Presence of these early findings in young patients despite the majority being on statin therapy support enhanced screening and aggressive treatment of familial hypercholesterolemia to prevent potential future cardiovascular events.

Entities:  

Keywords:  Atherosclerosis; Familial hypercholesterolemia; Magnetic resonance imaging (MRI); Pediatrics; Prevention

Mesh:

Substances:

Year:  2019        PMID: 31209684      PMCID: PMC6774880          DOI: 10.1007/s10554-019-01626-5

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  41 in total

1.  Imaging of atherosclerosis: carotid intima-media thickness.

Authors:  Daniel H O'Leary; Michiel L Bots
Journal:  Eur Heart J       Date:  2010-06-11       Impact factor: 29.983

2.  Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.

Authors:  Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde
Journal:  J Biomed Inform       Date:  2008-09-30       Impact factor: 6.317

3.  Long-Term Risk of Atherosclerotic Cardiovascular Disease in US Adults With the Familial Hypercholesterolemia Phenotype.

Authors:  Amanda M Perak; Hongyan Ning; Sarah D de Ferranti; Holly C Gooding; John T Wilkins; Donald M Lloyd-Jones
Journal:  Circulation       Date:  2016-07-05       Impact factor: 29.690

4.  Zoom imaging for rapid aortic vessel wall imaging and cardiovascular risk assessment.

Authors:  Tarique Hussain; Rachel E Clough; Marina Cecelja; Marcus Makowski; Sarah Peel; Philip Chowienczyk; Tobias Schaeffter; Gerald Greil; Rene Botnar
Journal:  J Magn Reson Imaging       Date:  2011-08       Impact factor: 4.813

5.  Anatomic correlates of aortic pulse wave velocity and carotid artery elasticity during atherosclerosis progression and regression in monkeys.

Authors:  D J Farrar; M G Bond; W A Riley; J K Sawyer
Journal:  Circulation       Date:  1991-05       Impact factor: 29.690

6.  Aortic compliance in young patients with heterozygous familial hypercholesterolaemia.

Authors:  E D Lehmann; G F Watts; B Fatemi-Langroudi; R G Gosling
Journal:  Clin Sci (Lond)       Date:  1992-12       Impact factor: 6.124

7.  Vascular calcifications in homozygote familial hypercholesterolemia.

Authors:  Z Awan; K Alrasadi; G A Francis; R A Hegele; R McPherson; J Frohlich; D Valenti; B de Varennes; M Marcil; C Gagne; J Genest; P Couture
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-01-31       Impact factor: 8.311

8.  Cardiovascular disease and mortality in statin-treated patients with familial hypercholesterolemia.

Authors:  M F Mohrschladt; R G J Westendorp; J A Gevers Leuven; A H M Smelt
Journal:  Atherosclerosis       Date:  2004-02       Impact factor: 5.162

9.  Mortality in treated heterozygous familial hypercholesterolaemia: implications for clinical management. Scientific Steering Committee on behalf of the Simon Broome Register Group.

Authors: 
Journal:  Atherosclerosis       Date:  1999-01       Impact factor: 5.162

10.  Time-resolved 3D MR velocity mapping at 3T: improved navigator-gated assessment of vascular anatomy and blood flow.

Authors:  Michael Markl; Andreas Harloff; Thorsten A Bley; Maxim Zaitsev; Bernd Jung; Ernst Weigang; Mathias Langer; Jürgen Hennig; Alex Frydrychowicz
Journal:  J Magn Reson Imaging       Date:  2007-04       Impact factor: 4.813

View more
  2 in total

Review 1.  The Importance of Arterial Stiffness Assessment in Patients with Familial Hypercholesterolemia.

Authors:  Beáta Kovács; Orsolya Cseprekál; Ágnes Diószegi; Szabolcs Lengyel; László Maroda; György Paragh; Mariann Harangi; Dénes Páll
Journal:  J Clin Med       Date:  2022-05-19       Impact factor: 4.964

2.  Myocardial strain impairment, heterozygous familial hypercholesterolemia and systemic arterial hypertension: Is there a link?

Authors:  Antonio Vitarelli
Journal:  Int J Cardiol Hypertens       Date:  2021-05-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.